Treatment with CCR2 antagonist is neuroprotective but does not alter epileptogenesis in the pilocarpine rat model of epilepsy
- 1 January 2020
- journal article
- research article
- Published by Elsevier in Epilepsy & Behavior
- Vol. 102, 106695
Abstract
No abstract availableKeywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2015/11119-4)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2016/08969-9)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (9630110615)
This publication has 35 references indexed in Scilit:
- Monocyte chemoattractant protein-1 affects migration of hippocampal neural progenitors following status epilepticus in ratsJournal of Neuroinflammation, 2013
- The COX-2 inhibitor parecoxib is neuroprotective but not antiepileptogenic in the pilocarpine model of temporal lobe epilepsyExperimental Neurology, 2010
- Chemokine CCL2 and its receptor CCR2 are increased in the hippocampus following pilocarpine-induced status epilepticusJournal of Neuroinflammation, 2009
- Pilocarpine-Induced Seizures Revisited: What Does the Model Mimic?Epilepsy Currents, 2009
- Enhanced microglial activation and proinflammatory cytokine upregulation are linked to increased susceptibility to seizures and neurologic injury in a ‘two-hit’ seizure modelBrain Research, 2009
- Expression of monocyte chemoattractant protein-1 in brain tissue of patients with intractable epilepsyClinical Neuropathology, 2008
- Local self-renewal can sustain CNS microglia maintenance and function throughout adult lifeNature Neuroscience, 2007
- Potential New Antiepileptogenic Targets Indicated by Microarray Analysis in a Rat Model for Temporal Lobe EpilepsyJournal of Neuroscience, 2006
- Identification of the Binding Site for a Novel Class of CCR2b Chemokine Receptor AntagonistsJournal of Biological Chemistry, 2000
- Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionatorThe Anatomical Record, 1991